Filing Flows › Cryo Cell International (CCEL) › Capital expenditures
Cryo Cell International (CCEL) capital expenditures by quarter
Cryo Cell International's capital expenditures were $102K in Q3 FY26 (third quarter fiscal 2026), +212% from Q2 FY26. Over the last 7 quarters it ranged from $33K (Q2 FY26) to $102K (Q3 FY26).
| Quarter | Capital expenditures | Q/Q | Y/Y |
|---|---|---|---|
| Q3 FY26 | $102K | +212% | +163% |
| Q2 FY26 | $33K | -51% | -48% |
| Q1 FY26 | $67K | -0.2% | +8% |
| Q4 FY25 | $67K | +73% | — |
| Q3 FY25 | $39K | -38% | — |
| Q2 FY25 | $62K | +0.6% | — |
| Q1 FY25 | $62K | — | — |
Q3 FY26 at a glance
Cryo Cell International, Q3 FY26: revenue $7.8M (0% year over year), operating margin 28.0%, net earnings $1.3M, operating cash flow $1.1M. The chart follows the revenue to costs, profit and cash.
Questions
What is Cryo Cell International's capital expenditures?
Cryo Cell International's capital expenditures were $102K in Q3 FY26 (third quarter fiscal 2026), +212% from Q2 FY26.
How has Cryo Cell International's capital expenditures changed?
Over the last 7 quarters it ranged from $33K (Q2 FY26) to $102K (Q3 FY26).
Q3 FY26 results → · How Cryo Cell International makes money →